A new technology that lets you get your hair cut in a matter of minutes has been hailed as a major step forward in the fight against skin cancer.
The Hair Salon Technologies Company, based in London, said its technology, called the Hair-Tek, was “a revolutionary new way to grow, control and maintain hair without damaging the skin” and is now being tested on a large number of patients.
The company’s CEO, Daniela Luzzatto, said the technology had already been applied to patients who had not been diagnosed with skin cancer and is also being tested in the treatment of a new type of skin cancer called erythema multiforme.
The technology, which was developed by the London-based HairTech, uses a laser to separate and remove the hair follicles from a patient’s scalp, then “further separates and removals” the hair from surrounding tissue.
“When we look at people with advanced erythromatosis, we see they have an extra layer of skin in between the hair and the bone marrow, which means they’re also more prone to infection,” Ms Luzzato said.
“The HairTech team has been working on hair-treating technology for years to help patients with this rare type of cancer get back hair, and we are now excited to be launching our Hair-Tech hair-growth technology in a large scale clinical trial with patients with advanced skin cancer.”‘
There’s no other option’For patients with more advanced skin cancers, a hair transplant may not be a viable option.
“In these patients, we have to treat them with a hair-suppressing drug that is not working,” Ms Poggio said.
She said patients were often advised by their doctors not to undergo a hair cut and were often given “alternative treatment” such as chemotherapy.
“There’s a lot of uncertainty in this area.
For a patient with advanced melanoma, there is no other choice, and they have to go through the process of chemotherapy,” she said.
Ms Luzzillo said the HairTech technology was designed to be as safe as possible, which is why the company is also launching a trial with a small number of the patients in the United States.
“This is the first time we have used this technology in the US.
It’s a trial that we are going to roll out across the United Kingdom and Europe and hopefully we will have a global launch in the coming months,” Ms Torelli said.
The trial, which will be launched in London’s east end in September, will see 20 patients aged between 45 and 65 undergo the hair transplant procedure.
A separate trial will also take place in the city of Leeds, where the technology is being used to help treat a type of erythyosis that can cause severe pain.
“I’m very excited that this is now going to be tested in people,” Ms Coggan said.
“I think it’s a very important tool for the patients who have been looking for a hair reduction option.”
Ms Cogans trial will be led by Dr Matthew Hockley, who is also the chairman of the Royal College of Physicians’ Department of Clinical Neurology and a professor at the University of Leeds.